A major scientific breakthrough announcement!
Dr. Tak Mak, Director of The Campbell Family Institute & Dr. Dennis Slamon from UCLA, two of the world's most acclaimed cancer researchers, shared news of a major breakthrough in the decade-long pursuit to develop a new class of "sharpshooter" cancer drugs.
» Read the full story
Why Personalized Cancer Medicine?
The Princess Margaret is setting a new gold standard for Personalized Cancer Medicine, which focuses on using a patient's unique genetic information to precisely diagnose their cancer and determine its prognosis. Find out why it is so important to everything we do.
» More about Personalized Cancer Medicine
Dr. Tak Mak
Dr. Tak Mak is Director of The Campbell Family Institute for Breast Cancer Research at The Princess Margaret. Not only is Dr. Mak recognized as one of the world's top cancer researchers, he has used his expertise in drug development to build a team, which is now preparing novel drugs for Phase 1 clinical trial.
Watch to learn more about Dr. Mak and his personal "Tao of discovery" - the origin and evolution of the "Eureka!" moment that ignited his career.
» More about Dr. Mak
RESEARCH IN FOCUS
IMPACT (Integrated Molecular Profiling in Advanced Cancer Trial) is a clinical trial being run at The Princess Margaret that will help advance Personalized Cancer Medicine by basing treatment on the molecular profile of each patient's tumour.
Dr. Bedard tells us about the IMPACT trial and how it is leading to new and better treatments for cancer patients.
» More about IMPACT